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SUMMARY
Here we present a rare combination of aortobronchial 
fistula and Listeria endograft infection after repeat 
endovascular aortic repair. Device retention, debridement 
and negative pressure wound therapy, in combination 
with suppressive antimicrobial therapy, led to satisfactory 
control of infection until the patient died due to another 
complication. The combination of an aortobronchial 
fistula and Listeria endograft infection has never been 
described before. This present case should encourage 
and show clinicians the importance of an interdisciplinary 
approach in highly difficult clinical courses.
BACKGROUND
Listeria monocytogenes is a Gram- positive, faculta-
tive, anaerobic, rod- shaped bacterium. The bacte-
rium crosses the intestinal barrier by endocytosis of 
endothelial cells, leading to bacteraemia and poten-
tial adhesion to the aortic wall or to stent grafts. L. 
monocytogenes is also associated with rare cases of 
mycotic aneurysm formation.1–3
Since the late 1990s thoracic endovascular aortic 
repair (TEVAR) and abdominal endovascular aortic 
repair (EVAR) have been increasingly used for repair 
of aortic pathology in elderly individuals. Thoracoab-
dominal endovascular aortic repair (T/EVAR) is asso-
ciated with a lower mortality rate,4 5 with a 30- day 
mortality rate of 0.2%–1.7% for endovascular repair 
compared with 2.3%–4.7% for open surgery.6–8 
Aortic endograft infection (AGI) is a feared compli-
cation with an incidence of 0.2%–5%.9 Prolonged 
antimicrobial treatment and graft excision are usually 
prerequisites to cure infection. We present the case 
of L. monocytogenes endovascular AGI complicated 
by an aortobronchial fistula which was successfully 
treated with fistula resection, patch repair, debride-
ment, negative pressure wound therapy (NPWT) and 
graft preservation.
CASE PRESENTATION
In July 2015, a 70- year- old patient with haemop-
tysis and intermittent fever presented to the emer-
gency department of the University Hospital Zurich 
in Switzerland. His medical history was remarkable 
for a T/EVAR of a large Crawford III thoracic and 
abdominal aortic aneurysm (figure 1),10 a supra- 
aortic and renovisceral debranching, and a coro-
nary artery bypass graft for three- vessel coronary 
heart disease (all procedures performed in 2007). 
Additionally a relining of the endovascular pros-
thesis had been performed in 2010.
On presentation in July 2015, the patient’s C 
reactive protein (CRP) and leucocyte count were 
elevated at 209 mg/L (reference range <5 mg/L) and 
14.9×109/L (reference range >9×109/L), respec-
tively. His haemoglobin was 97 g/L (reference range 
134–170 g/L). A thoracoabdominal CT angiography 
(CTA) showed a contrast- enhancing fluid collection 
around the endovascular stent with progression of the 
aortic aneurysm. This CTA did not show a fistulous 
communication between the aorta and the bronchial 
system. Two sets of blood cultures were drawn but 
were both negative. Empirical antimicrobial therapy 
with vancomycin and meropenem was initiated. After 
9 days of antibiotics, the patient was still experiencing 
fever and intermittent haemoptysis. Retention of the 
endovascular graft was decided in this elderly patient 
with a high surgical risk. The operation revealed 
an aortobronchial fistula, and a decision was made 
to perform resection of the aortobronchial fistula, 
volume reduction of the infected aneurysm bag and 
pericardial patch reconstruction. NPWT was initi-
ated and two dressing changes were necessary until 
wound closure (figure 2). During the second oper-
ation, the destroyed left lower lobe of the lung was 
partially resected under venovenous extracorporeal 
life support.
Within the first 14 days after lower lobe resection 
of the lung, the patient’s CRP ranged between 70 
and 180 mg/L, with a declining trend. Additionally, 
postoperative blood cultures were negative. After 
14 days of empirical treatment and 7 days after the 
first surgical revision, deep wound cultures were 
PCR- positive for L. monocytogenes. Additional 
microbiological cultures of respiratory secretions 
and from tissue of the fistulous communication 
grew Klebsiella pneumoniae and Candida albicans. 
Accordingly, the antimicrobial therapy was de- esca-
lated to amoxicillin/clavulanic acid and gentamicin 
for L. monocytogenes, and caspofungin was initiated 
for fungal infection. The patient was transferred to 
a hospital closer to his home town. Unfortunately, 
his rehabilitation was complicated by a superinfec-
tion of the previously operated aneurysm bag with 
Pseudomonas aeruginosa and a Stenotrophomonas 
maltophilia pneumonia. Antimicrobial treatment 
was changed to piperacillin/tazobactam, and inter-
mittently the patient was treated with trimetho-
prim/sulfamethoxazole for his pneumonia.
In quarterly clinical follow- ups by an infectious 
diseases physician, the patient was asymptomatic 
and remains under lifelong suppressive antimicro-
bial and antimycotic therapy (outpatient pipera-
cillin/tazobactam pump therapy and fluconazole 
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Figure 1 Initial computed tomography (CT) scan in 2015 with infected 
aneurysm bag (blue arrow).
Figure 2 Vacuum sealing/black sponge (green arrow) was placed in 
the partial resected aneurysm bag and covered up with xenopericardial 
patch (blue arrow). The images on the top left and right, as well as the 
bottom left image, the diaphragm and the lung, retracted with the hook, 
are shown.
Figure 3 Six- month follow- up without signs of an infected aneurysm 
bag (left image) compared with the previously infected aneurysm bag 
(right image).
per os). Repetitive CT scans showed stable conditions of the 
thoracoabdominal aortic aneurysm with good control of AGI 
(figure 3).
In November 2017, the patient was hospitalised due to an 
incarcerated abdominal hernia and subsequent ischaemia of the 
small bowel. After an emergency operation, the patient devel-
oped bilateral pneumonia, paralytic ileus and a new secondary 
AGI, leading to septic shock and ultimately death in December 
2017. Shortly before death, blood cultures and bronchoalveolar 
lavage were positive for Enterococcus faecium, K. pneumoniae 
and C. glabrata, without evidence of L. monocytogenes.
OUTCOME AND FOLLOW-UP
The combination of aortobronchial fistula and Listeria endog-
raft infection has never been described before. Device retention, 
debridement and NPWT, in combination with suppressive anti-
microbial therapy, led to a satisfactory control of infection until 
the patient died due to another complication.
DISCUSSION
We report a rare case of L. monocytogenes endograft infection 
presenting as an aortobronchial fistula.
Aortobronchial fistulae are described as potential complica-
tions after TEVAR due to very large aneurysms. The incidence 
of aortobronchial fistulae after TEVAR is estimated at 1.7%.11 
Repeat stenting might lead to graft erosion, with the increased 
pressure from the large aneurysm sac contributing to the occur-
rence of aortobronchial fistulae.12 Similar to the present case, an 
aortobronchial fistula might also lead to a secondary infection of 
the thoracic endograft.
The best surgical therapy for AGI is excision of the infected 
device, debridement of the infected soft tissues, and resto-
ration of the blood flow to the lower extremities and visceral 
arteries. Surgical options include extra- anatomical bypass or 
in situ prosthetic graft reconstruction with or without omental 
wrapping. However, many T/EVAR patients are not suitable 
candidates for open surgery, and graft excision is associated 
with high perioperative mortality, ranging from 15% to 41%. 
More so in patients undergoing TEVAR with excisions, a more 
proximal cross clamping of the aorta descendens—associated 
with potential spinal cord or reperfusion injury—is required, 
compared with EVAR patients. Additionally, the need for left 
heart bypass and aortic fistulation complicate the perioperative 
management. Therefore, in selected patients with high perioper-
ative risk, TEVAR retention might be considered. In our case, a 
conservative treatment with antimicrobial therapy alone could 
not control the patient’s condition due to the unknown fistula 
at that time. Therefore, aside from a surgical approach with 
debridement of the aneurysm sac and a pulmonary parenchymal 
repair, an NPWT device was used. The application of povidone- 
iodine- soaked towels in the chest cavity with negative pressure 
via chest tubes has been previously reported for management of 
complicated infections.13 However, NPWT is not yet well estab-
lished for intrathoracic use,13 14 and the most promising effect, 
when used as an adjunct to surgery, is permanent drainage of the 
infected area.14
L. monocytogenes infection is a foodborne disease that usually 
affects the elderly or immunosuppressed patients, pregnant 
women or neonates. Invasive listeriosis usually results in menin-
gitis or bacteraemia. However, rare cases of endograft infections 
due to L. monocytogenes have also been reported (table 1).1 9 15–18
According to the literature, patients with Listeria endograft 
infection present with fever and/or pain, as was the case in 
our patient. Additionally, L. monocytogenes is rarely detected 
in blood cultures and requires selective media for growth from 
tissue cultures. This indicates that endograft infections with L. 
monocytogenes usually have non- specific symptoms, and there-
fore clinicians should be vigilant during examination of such 
patients.3 19 20 Intravenous penicillin or amoxicillin with or 
without the synergistic combination of gentamicin is the treat-
ment of choice. The optimal treatment duration is unknown 
and should be decided based on the extent of infection and the 
patient’s comorbidities. In our patient with retained TEVAR, we 
decided to go for a lifelong suppressive antimicrobial therapy.
The combination of aortobronchial fistula and Listeria endo-
graft infection has never been described before. Device reten-
tion, debridement and NPWT, in combination with suppressive 
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surgery Surgical treatment Medical treatment Follow- up Outcome
Saleem et al9 1 Male 61 EVAR 7 months Conservative. Amoxicillin/clavulanic acid,
cotrimoxazole.
1 year and 7 
months
Alive
Heikkinen et al15 1 Male 77 EVAR Not stated In situ reconstruction with 
complete removal of the 
infected stent.
Not stated. 10 months Alive
Cernohorsky et 
al16





1 Male 51 EVAR 2 years Not stated. Not stated. Not stated Not stated
Silvestri and 
Isernia18
1 Female 72 TEVAR 7 years Conservative. Cotrimoxazole/gentamicin. 10 days Died




Yamamoto et al1 1 Male 82 EVAR 14 months In situ reconstruction with 





Present case 1 Male 70 TEVAR 10 years Fistula resection, patch repair, 
debridement, negative pressure 
wound therapy and graft 
preservation.
Amoxicillin/clavulanic acid, 
gentamicin at the start of 
treatment.
2 years and 4 
months
Died
EVAR, endovascular aortic repair; TEVAR, thoracic endovascular aortic repair.
antimicrobial therapy, led to a satisfactory control of infection 
until the patient died due to another complication.
Learning points
 ► This case should encourage and show clinicians the 
importance of an interdisciplinary approach in highly difficult 
and abnormal clinical courses.
 ► Negative pressure wound therapy is a useful therapeutic 
approach to intrathoracic infections.
 ► Endograft infections with Listeria monocytogenes are very 
rare.
 ► Repeat thoracoabdominal endovascular aortic repair and 
realigning procedures may lead to complications.
 ► Endograft infections, especially with arising fistula, should be 
treated surgically.
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